CRP and cancer: Elements of systemic inflammation, such as platelets, lymphocytes and high-sensitivity C-reactive protein (hs-CRP), and biochemical markers in the blood, such as C-reactive protein levels and albumin levels, are valuable prognostic indicators for cancer, including breast cancer (Takamizawa et al., 2020).